Respivant Sciences
  • Home
  • Disease
  • Product
  • About
  • News
  • Careers
  • Contact
Select Page

No current openings

We do not currently have any open positions. Please check back soon.

Please submit your resume to: careers@respivant.com

Recent Posts

  • Manager/Director, Quality Assurance
  • 5.20.2019 – Respivant Sciences Announces Dosing of First Patient in Phase 2b Trial of RVT-1601 for the Treatment of Persistent Cough Due to Idiopathic Pulmonary Fibrosis
  • No current openings
  • 9.17.2018 – Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases
  • 9.9.2018 – Roivant Adds Investigational Therapeutic for the Treatment of Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis to Pipeline

Designed by Elegant Themes | Powered by WordPress

Copyright 2019 Respivant Sciences, Inc | Privacy Policy

Shimbor: C, et al, Thorax 2019.

Birring S, et al, Lancet Resp Med 2017

Ryerson, et. al, Respirology 2011

Wygrecka M et al. Am J Pathology 2013; Overed-Sayer, et al 2014; Kawanami, 1979; Rosa & Fantozzi, 2013; Gatti et al, 2006; Jonhson, 2016; Okayama, 1992; Yazid S et al. Plos One 2013

Lederer and Martinez, New Eng Jrnl Med 2018

Proprietary Company data; Pham, et. al, Jrnl Arsl Mdcn Pul Drug Dlvry 2018